Equity Overview
Price & Market Data
Price: $0.074
Daily Change: -$0.0125 / 16.86%
Daily Range: $0.074 - $0.0865
Market Cap: $6,995,967
Daily Volume: 5,630
Performance Metrics
1 Week: -8.73%
1 Month: -9.92%
3 Months: -17.72%
6 Months: 7.97%
1 Year: 28,727%
YTD: -38.71%
Details
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert for determining smoking status; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas.